BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16113065)

  • 1. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.
    Fang X; Hu S; Xu B; Snyder GD; Harmon S; Yao J; Liu Y; Sangras B; Falck JR; Weintraub NL; Spector AA
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H55-63. PubMed ID: 16113065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors.
    Fang X; Hu S; Watanabe T; Weintraub NL; Snyder GD; Yao J; Liu Y; Shyy JY; Hammock BD; Spector AA
    J Pharmacol Exp Ther; 2005 Jul; 314(1):260-70. PubMed ID: 15798002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
    Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
    Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
    Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
    Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.
    Oltman CL; Weintraub NL; VanRollins M; Dellsperger KC
    Circ Res; 1998 Nov; 83(9):932-9. PubMed ID: 9797342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition.
    Fang X; Kaduce TL; Weintraub NL; Harmon S; Teesch LM; Morisseau C; Thompson DA; Hammock BD; Spector AA
    J Biol Chem; 2001 May; 276(18):14867-74. PubMed ID: 11278979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
    Diani-Moore S; Ma Y; Gross SS; Rifkind AB
    Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels.
    Fang X; Weintraub NL; McCaw RB; Hu S; Harmon SD; Rice JB; Hammock BD; Spector AA
    Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2412-20. PubMed ID: 15284062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional implications of a newly characterized pathway of 11,12-epoxyeicosatrienoic acid metabolism in arterial smooth muscle.
    Fang X; Kaduce TL; Weintraub NL; VanRollins M; Spector AA
    Circ Res; 1996 Oct; 79(4):784-93. PubMed ID: 8831502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of epoxyeicosatrienoic acids on cellular function.
    Spector AA; Norris AW
    Am J Physiol Cell Physiol; 2007 Mar; 292(3):C996-1012. PubMed ID: 16987999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles.
    Gauthier KM; Olson L; Harder A; Isbell M; Imig JD; Gutterman DD; Falck JR; Campbell WB
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F765-72. PubMed ID: 21753077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels.
    Campbell WB; Deeter C; Gauthier KM; Ingraham RH; Falck JR; Li PL
    Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1656-64. PubMed ID: 11959628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids.
    Weintraub NL; Fang X; Kaduce TL; VanRollins M; Chatterjee P; Spector AA
    Circ Res; 1997 Aug; 81(2):258-67. PubMed ID: 9242187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive LC-MS/MS method for the quantification of regioisomers of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in human plasma during endothelial stimulation.
    Duflot T; Pereira T; Roche C; Iacob M; Cardinael P; Hamza NE; Thuillez C; Compagnon P; Joannidès R; Lamoureux F; Bellien J
    Anal Bioanal Chem; 2017 Mar; 409(7):1845-1855. PubMed ID: 27981341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.
    Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids.
    Marowsky A; Meyer I; Erismann-Ebner K; Pellegrini G; Mule N; Arand M
    Arch Toxicol; 2017 Nov; 91(11):3571-3585. PubMed ID: 28975360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid-binding proteins inhibit hydration of epoxyeicosatrienoic acids by soluble epoxide hydrolase.
    Widstrom RL; Norris AW; Van Der Veer J; Spector AA
    Biochemistry; 2003 Oct; 42(40):11762-7. PubMed ID: 14529287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydroxyeicosatrienoic acids are potent activators of Ca(2+)-activated K(+) channels in isolated rat coronary arterial myocytes.
    Lu T; Katakam PV; VanRollins M; Weintraub NL; Spector AA; Lee HC
    J Physiol; 2001 Aug; 534(Pt 3):651-67. PubMed ID: 11483698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins.
    Yang T; Peng R; Guo Y; Shen L; Zhao S; Xu D
    Lipids Health Dis; 2013 Oct; 12():151. PubMed ID: 24148690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide.
    Fang X; Weintraub NL; Oltman CL; Stoll LL; Kaduce TL; Harmon S; Dellsperger KC; Morisseau C; Hammock BD; Spector AA
    Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2306-14. PubMed ID: 12388281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.